Statin treatment is not associated with an increased risk of adrenal insufficiency in real-world setting

Frontiers in Endocrinology

Endocrinology

Thomas Duroux¹  Lise Duranteau²  Sandy Maumus-Robert³  Ana Jarne-Munoz³  Antoine Pariente⁴  Julien Bezin⁴ 

[1] Health Information Department, ELSAN Group, Paris, France;Medical Gynaecology Department, AP-HP Paris Saclay University, Bicêtre Hospital, Paris, France;University Bordeaux, INSERM, Bordeaux Population Health (BPH), Team AHeaD, Bordeaux, France;University Bordeaux, INSERM, Bordeaux Population Health (BPH), Team AHeaD, Bordeaux, France;CHU de Bordeaux, Clinical Pharmacology Unit, INSERM, Bordeaux, France;

关键词: statins;    adrenal insufficiency;    risk;    pharmacoepidemiology;    database;   

DOI  :  10.3389/fendo.2023.1254221

 received in 2023-07-06, accepted in 2023-09-08,  发布年份 2023

来源: Frontiers

【 摘 要 】

IntroductionStatins could reduce the synthesis of steroid hormones, thereby could cause adrenal insufficiency. We investigated this risk in a large nationwide database.MethodsWe conducted a nested case-control study using a cohort of individuals affiliated to the French health insurance system in 2010, ≥18y and without adrenal insufficiency history. Each case had a first event of adrenal insufficiency between 2015 and 2017 and was matched to up to ten controls on age, sex, and prior treatment with corticosteroids. Statin exposure was measured over the five years preceding the index date, considering a six-month censoring lag-time. Association was estimated using a conditional logistic regression adjusted for confounders included in a disease risk score. Analyses were stratified on age, sex and corticosteroid history of use.Results4 492 cases of adrenal insufficiency were compared with 44 798 controls (median age 66y, 58% women), of which 39% vs. 33% were exposed to statins, respectively. No association between statin use and adrenal insufficiency was found when adjusting the model for confounders (adjusted odds ratio 0.98; 95% confidence interval 0.90-1.05). These results were consistent regardless of the exposure definition and stratifications considered.ConclusionStatin-related adrenal insufficiency risk, if any, seems to be very limited and does not compromise the benefit of statin treatment.

【 授权许可】

Unknown   
Copyright © 2023 Maumus-Robert, Jarne-Munoz, Pariente, Duroux, Duranteau and Bezin